Systemic delivery of TNF-Related Apoptosis-Inducing Ligand (TRAIL) elevates levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and prevents type 1 diabetes in nonobese diabetic mice

Endocrinology

Volumn 151, Issue 12, 2010, Pages 5638-5646

  Kang, Soojeong ^a   Park, Eun Jin ^a   Joe, Yeonsoo ^a   Seo, Eunhui ^a   Park, Mi Kyoung ^a   Seo, Su Young ^a   Chung, Hae Young ^b   Yoo, Young Hyun ^a   Kim, Duk Kyu ^a   Lee, Hye Jeong ^a  

^a Dong A University College of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GLUCOSE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD LEVEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LIVER LEVEL; MOUSE; NONHUMAN; PANCREAS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; ZYMOGRAPHY;

ANIMALS; BLOOD GLUCOSE; CELL LINE; DIABETES MELLITUS, TYPE 1; GENE THERAPY; HUMANS; MICE; MICE, INBRED NOD; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 78649876238     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0478     Document Type: Article

References (34)

1. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA 1995 Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682
2. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR, Strom SC 2000 Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6:564-567
3. Nitsch R, Bechmann I, Deisz RA, Haas D, Lehmann TN, Wendling U, Zipp F 2000 Human brain-cell death induced by tumour-necrosis- factor-related apoptosis-inducing ligand (TRAIL). Lancet 356: 827-828
4. Lamhamedi-Cherradi S-E, Zheng S, Maguschak K, Peschon J, Chen YH 2003 Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice. Nat Immunol 4:255-260
5. Simon AK, Williams O, Mongkolsapaya J, Jin B, Xu XN, Walczak H, Screaton GR 2001 Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes. Proc Natl Acad Sci USA 98:5158-5163 (Pubitemid 32397099)
6. Zheng SJ, Chen YH 2003 TRAIL, Bim, and thymic-negative selection. Immunol Res 28:295-301
7. Song K, Chen Y, Goke R, Wilmen A, Seidel C, Goke A, Hilliard B, Chen Y 2000 Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med 191:1095-1104 (Pubitemid 30207673)
8. Hilliard B, Wilmen A, Seidel C, Liu TS, Goke R, Chen Y 2001 Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J Immunol 166:1314-1319
9. Lamhamedi-Cherradi SE, Zheng S, Tisch RM, Chen YH 2003 Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes. Diabetes 52:2274-2278
10. Mi QS, Ly D, Lamhamedi-Cherradi SE, Salojin KV, Zhou L, Grattan M, Meagher C, Zucker P, Chen YH, Nagle J, Taub D, Delovitch TL 2003 Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice. Diabetes 52:1967-1975
11. Overall CM 1994 Regulation of tissue inhibitor of metalloproteinase expression. Ann NY Acad Sci 732:51-64
12. Fata JE, Leco KJ, Moorehead RA, Martin DC, Khokha R 1999 Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development. Dev Biol 211: 238-254
13. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K 1992 Growth promoting activity of tissue inhibitor of metalloproteinases- 1 (TIMP-1) for a wide range of cells: a possible new growth factor in serum. FEBS Lett 298:29-32
14. Bertaux B, Hornebeck W, Eisen AZ, Dubertret L 1991 Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 97:679-685
15. Khokha R, Zimmer MJ, Graham CH, Lala PK, Waterhouse P 1992 Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst 84:1017-1022
16. Guedez L, Statler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A, Stetler-Stevenson M 1998 In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases- 1. J Clin Invest 102:2002-2010
17. Li G, Fridman R, Kim HR 1999 Tissue inhibitor of metalloproteinase- 1 inhibits apoptosis of human breast epithelial cells. Cancer Res 59:6267-6275
18. Lin H, Chen X, Wang J, Yu Z 2002 Inhibition of apoptosis in rat mesangial cells by tissue inhibitor of metalloproteinase-1. Kidney Int 62:60-69
19. Oelmann E, Herbst H, Zuhlsdorf M, Albrecht O, Nolte A, Schmitmann C, Manzke O, Diehl V, Stein H, Berdel WE 2002 Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells. Blood 99:258-267
20. Jiang H, Zhu H, Chen X, Peng Y, Wang J, Liu F, Shi S, Lu BFY, Hong Q, Feng Z, Hou K, Sun X, Cai G, Zhang X, Xie Y 2007 TIMP-1 transgenic mice recover from diabetes induced by multiple low-dose streptozotocin. Diabetes 56:49-56
21. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB 1992 Establishment of 2-mercaptoethanol dependent differentiated insulin- secreting cell lines. Endocrinology 130:167-178
22. Chen G, Hohmeier HE, Gasa R, Tran VV, Newgard CB 2000 Selection of insulinoma cell lines with resistance to interleukin-1β- and γ-interferon-induced cytotoxicity. Diabetes 49:562-570
23. Graham FL, Smiley J, Russell WC, Nairn R 1997 Characteristics of human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59-74
24. Teng B, Blumenthal S, Forte T, Navaratnam N, Scott J, Gotto AM, Chan L 1994 Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. J Biol Chem 269:29359-29404
25. Lacy PE, Kostianovsky M 1967 Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16:35-39
26. Gotoh TM, Kiyoizumi T, Satomi S Monaco AP 1985 An improved method for the isolation of mouse pancreatic islet. Transplantation 40:437-438
27. Zacchigna S, Zentilin L, Morini M, Dell'Eva R, Noonan DM, Albini A, Giacca1 M 2004 AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo. Cancer Gene Ther 11:73-80
28. Cretney E, McQualter JL, Kayagaki N, Yagita H, Bernard CA, Grewal IS, Ashkenazi A, Smyth MJ 2005 TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice. Immunol Cell Biol 83:511-519
29. Wu GS, Burns TF, Zhan Y, Alnemri ES, El-Deiry WS 1999 Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor1in mice. Cancer Res 59:2770-2775
30. Han X, Sun Y, Scott S, Bleich D 2001 Tissue inhibitor of metalloproteinase- 1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and b-cells. Diabetes 50:1047-1055
31. Matrisian LM 1990 Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121-125
32. Maxwell PR, Timms PM, Chandran S, Gordon D 2001 Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes. Diabet Med 18:777-780
33. Descamps FJ, Martens E, Ballaux F, Geboes K, Opdenakker G 2004 In vivo activation of gelatinase B/MMP-9 by trypsin in acute pancreatitis is a permissive factor in streptozotocin-induced diabetes. J Pathol 204:555-561
34. Xue M, Yhompson PJ, Clifton-Bligh R, Fulcher G, Gallery EDM, Jackson C 2005 Leukocyte matrix netalloproteinase-9 in elevated and contributes to lymphocyte activation in type 1 diabetes. Int J Biochem Cell Biol 37:2406-2416